UMIN-ICDS Clinical Trial
| Unique ID issued by UMIN | UMIN000063202 |
|---|---|
| Receipt number | R000072254 |
| Scientific Title | Effects of Exercise Loads on Subsequent Physical Activity |
| Date of disclosure of the study information | 2026/10/07 |
| Last modified on | 2026/10/07 11:27:19 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Effects of Exercise on Subsequent Physical Activity
Acronym
Exercise and Subsequent Physical Activity Study
Scientific Title
Effects of Exercise Loads on Subsequent Physical Activity
Scientific Title:Acronym
Effects of Exercise Loads on Subsequent Physical Activity
Region
| Japan |
Condition
Condition
Physical Activity
Classification by specialty
| Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To determine compensatory responses in physical activity following different exercise loads.
Basic objectives2
Others
Basic objectives -Others
To determine the association between physical activity following different exercise loads and established indicators of internal load.
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Physical activity following different exercise loads
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Cross-over
Randomization
Randomized
Randomization unit
Individual
Blinding
Open -but assessor(s) are blinded
Control
No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
3
Purpose of intervention
Educational,Counseling,Training
Type of intervention
| Other |
Interventions/Control_1
80 min of Treadmill exercise at 75% VO2max
Interventions/Control_2
20 min of Treadmill exercise at 55% VO2max
Interventions/Control_3
110 min of sitting
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| 39 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
1) Individuals aged 18-39 years
2) Individuals affiliated with the research institution
Key exclusion criteria
1. Individuals with a history of hypertension or cardiovascular disease
2. Individuals who have been diagnosed with an eating disorder by a physician and are currently receiving medical treatment or taking medication for the condition
3. Individuals who have been diagnosed with a psychiatric disorder by a physician and are currently receiving medical treatment or taking medication for the condition
4. Individuals who have been diagnosed with a sleep disorder by a physician and are currently receiving medical treatment or taking medication for the condition
5. Individuals who have been diagnosed with an orthopedic disorder by a physician and are currently receiving medical treatment or taking medication for the condition
6. Individuals who have been diagnosed with a metabolic disorder by a physician and are currently receiving medical treatment or taking medication for the condition
7. Individuals who habitually consume excessive amounts of alcohol
8. Individuals who habitually smoke
9. Individuals with a medical condition or individual characteristic that is considered likely to substantially affect their ability to perform running exercise or the assessment of physical activity
10. Individuals who have been diagnosed with overreaching or overtraining
11. Individuals with markedly irregular sleep-wake rhythms due to night-shift work or other circumstances
12. Individuals with allergies to any foods contained in the standardized meals, including eggs, milk, wheat, beef, sesame, mackerel, soybeans, chicken, pork, bananas, apples, gelatin, almonds, or fish sauce
13. Individuals who are unable to install the application used for heart rate variability measurement or who do not agree to use the application
14. Individuals with an allergy to synthetic resins
Target sample size
32
Research contact person
Name of lead principal investigator
| 1st name | Haruka |
| Middle name | |
| Last name | Murakami |
Organization
Ritsumeikan University
Division name
College of Sport and health science
Zip code
525-8577
Address
1-1-1 Nojihigashi, Kusatsu, SHIGA
TEL
077-561-2890
haruka-m@fc.ritsumei.ac.jp
Public contact
Name of contact person
| 1st name | Haruka |
| Middle name | |
| Last name | Murakami |
Organization
Ritsumeikan University
Division name
College of Sport and health science
Zip code
525-8577
Address
1-1-1 Nojihigashi, Kusatsu, SHIGA
TEL
077-561-2890
Homepage URL
haruka-m@fc.ritsumei.ac.jp
Sponsor or person
Institute
Ritsumeikan University
Institute
Department
Personal name
Haruka Murakami
Funding Source
Organization
Ritsumeikan University
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Japan
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Ritsumeikan University
Address
1-1-1 Nojihigashi, Kusatsu, SHIGA
Tel
077-599-4175
b-rinri@st.ritsumei.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2026 | Year | 10 | Month | 07 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2026 | Year | 09 | Month | 17 | Day |
Date of IRB
| 2026 | Year | 09 | Month | 17 | Day |
Anticipated trial start date
| 2026 | Year | 10 | Month | 12 | Day |
Last follow-up date
| 2027 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2026 | Year | 10 | Month | 07 | Day |
Last modified on
| 2026 | Year | 10 | Month | 07 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072254
